Literature DB >> 8690524

Adenomatous transformation of the human anterior pituitary is associated with alterations in integrin expression.

M R Farnoud1, N Veirana, P Derome, F Peillon, J Y Li.   

Abstract

Integrins are heterodimeric transmembrane molecules that mediate cell-cell and cell-substratum adhesion. Because alterations in the adhesive properties of tumor cells influence tumor growth and progression, the distribution of different alpha and beta integrin subunits was studied in both the parenchyma and the connective tissue in 6 normal and 25 adenomatous human anterior pituitaries. All normal parenchymal cells expressed the alpha3beta1 and alpha6beta4 integrins. By contrast, in adenomatous parenchymal cells the expression of alpha3beta1 was down-regulated and that of alpha6beta4 abrogated. Neoexpression of alphavbeta3 Occurred in the parenchyma of a subset of adenomas. All normal connective tissue cells expressed the alpha1 and beta1 subunits, a third subunit (alpha5) being present in the normal endothelium. By comparison, all adenomatous stromal cells expressed many more integrin subunits (alpha1, alpha3, alpha5, alphav, beta1 and beta3), adenomatous endothelial cells bearing additional subunits (alpha6, beta4 and beta5). Vitronectin, absent from the normal connective tissue, was constantly observed in the adenomatous stroma. To conclude, compared with cells of the normal gland, adenomatous anterior pituitary cells display a decreased expression of integrins whereas the adenomatous stroma expresses a rich repertoire of integrins. These changes are not related to the secretory type, grade or invasiveness of the adenoma. The resulting alterations in the adhesive properties of adenomatous cells could facilitate their dissemination. Enrichment of the integrin repertoire expressed by the adenomatous vasculature is indicative of its dual nature, systemic and tumoral.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690524     DOI: 10.1002/(SICI)1097-0215(19960703)67:1<45::AID-IJC10>3.0.CO;2-B

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.

Authors:  Evan Phillips; Oula Penate-Medina; Pat B Zanzonico; Richard D Carvajal; Pauliah Mohan; Yunpeng Ye; John Humm; Mithat Gönen; Hovanes Kalaigian; Heiko Schöder; H William Strauss; Steven M Larson; Ulrich Wiesner; Michelle S Bradbury
Journal:  Sci Transl Med       Date:  2014-10-29       Impact factor: 17.956

2.  Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.

Authors:  Slawomir A Mucha; Gabriela Meleń-Mucha; Andrzej Godlewski; Henryk Stepień
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

3.  The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.

Authors:  Ozgur Mete; Caroline Hayhurst; Hussein Alahmadi; Eric Monsalves; Hasan Gucer; Fred Gentili; Shereen Ezzat; Sylvia L Asa; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

4.  The expression of integrinbeta1 and FAK in pituitary adenomas and their correlation with invasiveness.

Authors:  Feng Wang; Kai Shu; Ting Lei; Delin Xue
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

5.  Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis.

Authors:  Richard H Kimura; Ling Wang; Bin Shen; Li Huo; Willemieke Tummers; Fabian V Filipp; Haiwei Henry Guo; Thomas Haywood; Lotfi Abou-Elkacem; Lucia Baratto; Frezghi Habte; Rammohan Devulapally; Timothy H Witney; Yan Cheng; Suhas Tikole; Subhendu Chakraborti; Jay Nix; Christopher A Bonagura; Negin Hatami; Joshua J Mooney; Tushar Desai; Scott Turner; Richard S Gaster; Andrea Otte; Brendan C Visser; George A Poultsides; Jeffrey Norton; Walter Park; Mark Stolowitz; Kenneth Lau; Eric Yang; Arutselvan Natarajan; Ohad Ilovich; Shyam Srinivas; Ananth Srinivasan; Ramasamy Paulmurugan; Juergen Willmann; Frederick T Chin; Zhen Cheng; Andrei Iagaru; Fang Li; Sanjiv S Gambhir
Journal:  Nat Commun       Date:  2019-10-14       Impact factor: 14.919

Review 6.  The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.

Authors:  Mirela Diana Ilie; Alexandre Vasiljevic; Gérald Raverot; Philippe Bertolino
Journal:  Cancers (Basel)       Date:  2019-10-21       Impact factor: 6.639

Review 7.  Pituitary Hyperplasia, Hormonal Changes and Prolactinoma Development in Males Exposed to Estrogens-An Insight From Translational Studies.

Authors:  Branka Šošić-Jurjević; Vladimir Ajdžanović; Dragana Miljić; Svetlana Trifunović; Branko Filipović; Sanja Stanković; Sergey Bolevich; Vladimir Jakovljević; Verica Milošević
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

8.  TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.

Authors:  Ya Wang; Tingting Cheng; Miaolong Lu; Yun Mu; Biao Li; Xuejun Li; Xianquan Zhan
Journal:  EPMA J       Date:  2019-08-29       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.